Hexarelin news and clinical trials
Also known as: Examorelin · Hexarelin acetate · EP-23905 · MF-6003
Updated 26 sources
4 new studies in the last 12 months, newest first: trial registrations and results, PubMed papers, FDA actions and press coverage that name Hexarelin. Each line links to the primary source.
September 2026
- StudyPubMedHistopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice (opens PubMed)
Researchers published a study in the Journal of molecular histology evaluating Hexarelin in mice with MPTP-associated pancreatic injury. Findings showed that Hexarelin treatment attenuated pancreatic inflammation and apoptosis while partially preserving islet morphology.
Journal of molecular histologyPMID 42758352
August 2026
- StudyPubMedProtective and restorative effects of hexarelin on MPTP-induced lung injury in mice (opens PubMed)
A study in the Journal of basic and clinical physiology and pharmacology examined Hexarelin against MPTP-induced lung injury in mice. Hexarelin reduced histopathological damage and improved immunohistochemical parameters by mitigating oxidative stress, inflammation, and apoptosis.
Journal of basic and clinical physiology and pharmacologyPMID 42619489
July 2026
- StudyPubMedThe emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration (opens PubMed)
A review of peptides modulating the GH-IGF-1 axis highlights the significant gap between clinical evidence and unregulated self-administration protocols. Clinicians are advised to recognize potential adverse effects like endocrine disturbances, fluid retention, and metabolic issues.
Frontiers in endocrinologyReviewPMID 42395176
March 2026
- StudyPubMedHexarelin promotes the survival of retinal ganglion cells after optic nerve transection (opens PubMed)
A study in the Indian journal of pharmacology investigated Hexarelin's neuroprotective effects on retinal ganglion cells after optic nerve transection in hamsters. Results indicated that Hexarelin increased cell survival in a dose-dependent manner, with 150 μg/kg twice daily being optimal.
Indian journal of pharmacologyPMID 41766237
Searched as: Hexarelin, Examorelin, EP-23905, MF-6003. Summaries are one or two sentences, published only when every number in them appears in the source record. A tracker, not medical advice.